Point72 Asset Management’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-18
Closed -$364 1740
2023
Q3
$364 Buy
+18
New +$364 ﹤0.01% 1691
2023
Q1
Sell
-132,774
Closed -$6.77M 1858
2022
Q4
$6.77M Buy
132,774
+132,541
+56,885% +$6.76M 0.02% 584
2022
Q3
$19K Buy
+233
New +$19K ﹤0.01% 963
2020
Q4
Sell
-23,315
Closed -$5.11M 974
2020
Q3
$5.11M Buy
+23,315
New +$5.11M 0.03% 511
2019
Q3
Sell
-173,088
Closed -$15.6M 1243
2019
Q2
$15.6M Buy
+173,088
New +$15.6M 0.08% 264
2019
Q1
Sell
-102,781
Closed -$14.4M 1010
2018
Q4
$14.4M Buy
102,781
+46,081
+81% +$6.48M 0.07% 289
2018
Q3
$14.5M Sell
56,700
-39,446
-41% -$10.1M 0.06% 288
2018
Q2
$24.5M Sell
96,146
-34,422
-26% -$8.77M 0.1% 198
2018
Q1
$26.3M Sell
130,568
-92,898
-42% -$18.7M 0.11% 197
2017
Q4
$32.2M Buy
+223,466
New +$32.2M 0.14% 161
2014
Q4
Sell
-2,627
Closed -$1.38M 705
2014
Q3
$1.38M Buy
2,627
+2,094
+393% +$1.1M 0.01% 487
2014
Q2
$372K Buy
+533
New +$372K ﹤0.01% 608